To the extent possible under law, AOP-Wiki has waived all copyright and related or neighboring rights to KER:974
reduced dimerization, ARNT/HIF1-alpha leads to reduced production, VEGF
Key Event Relationship Overview
AOPs Referencing Relationship
|AOP Name||Adjacency||Weight of Evidence||Quantitative Understanding||Point of Contact||Author Status||OECD Status|
|Aryl hydrocarbon receptor activation leading to early life stage mortality, via reduced VEGF||adjacent||Moderate||Moderate||Amani Farhat (send email)||Open for citation & comment||WPHA/WNT Endorsed|
|AhR activation leading to preeclampsia||adjacent||Sabrina Tait (send email)||Under development: Not open for comment. Do not cite||Under Development|
Life Stage Applicability
|During development and at adulthood||High|
Key Event Relationship Description
Dimerization between AHR nuclear translocator (ARNT) and hypoxia inducible factor 1 alpha (HIF-1α) forms a transcription factor complex (HIF-1) that binds to hypoxia response enhancer sequences on DNA to activate the expression of angiogenic factors including vascular endothelial growth factor (VEGF) (Fong 2009). The HIF-1 complex binds to the VEGF gene promoter, then recruits additional transcriptional factors such as P-CREB and P-STAT3, to the promoter and initiates VEGF transcription (Ahluwalia and Tarnawski 2012). In the absence of HIF-1, VEGF expression and secretion is diminished.
Evidence Collection Strategy
Evidence Supporting this KER
The transcriptional control of VEGF by HIF-1 is well understood (Ahluwalia and Tarnawski 2012; Fong 2009)
Uncertainties and Inconsistencies
- ARNT knock-out in mice (effectively null for HIF-1) show disrupted angiogenesis and reduced VEGF expression (Maltepe et al. 1997); however, HIF-1α null mice (also effectively null for HIF-1) show disrupted angiogenesis with a slight increase in VEGF expression (Compernolle et al. 2003). This may indicate that alternate, compensatory mechanisms for transcriptional regulation of VEGF exist, which are HIF-1α-independent but ARNT dependent.
- There is also the potential for HIF-1-independent regulation of VEGF, as illustrated in an ARNT-deficient mutant cell line (Hepa1 C4) in which VEGF expression was only partially abrogated (Gassmann et al. 1997).
- It has been reported that the AHR/ARNT heterodimer binds to estrogen response elements, with mediation of the estrogen receptor (ER), and activates transcription of VEGF-A (Ohtake et al. 2003). The potential involvement of AHR in opposing regulatory cascades (directly inducing VEGF through ER and indirectly suppressing it by ARNT sequestration) also helps explain conflicting results found in the literature.
Known modulating factors
Known Feedforward/Feedback loops influencing this KER
Domain of Applicability
Transcriptional regulation of VEGF by the HIF-1 complex has been demonstrated in chicken embryos (Cheung 1997; Ivnitski-Steele et al. 2004), Baltic salmon (Vuori et al. 2004), mice (Maltepe et al. 1997) and rats (Levy et al.1995). This KER is likely applicable in general to birds, fish and mammals based on the conserved nature of the VEGF gene (Masabumi Shibuya 2002).
1. Ahluwalia, A., and Tarnawski, A. S. (2012). Critical role of hypoxia sensor--HIF-1alpha in VEGF gene activation. Implications for angiogenesis and tissue injury healing. Curr. Med. Chem 19(1), 90-97.
2. Cheung, C. Y. (1997). Vascular endothelial growth factor: possible role in fetal development and placental function. J Soc. Gynecol. Investig. 4(4), 169-177.
3. Fong, G. H. (2009). Regulation of angiogenesis by oxygen sensing mechanisms. J Mol. Med. (Berl) 87(6), 549-560.
4. Ivnitski-Steele, I. D., Friggens, M., Chavez, M., and Walker, M. K. (2005). 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) inhibition of coronary vasculogenesis is mediated, in part, by reduced responsiveness to endogenous angiogenic stimuli, including vascular endothelial growth factor A (VEGF-A). Birth Defects Res. A Clin Mol. Teratol. 73(6), 440-446.
5. Ivnitski-Steele, I. D., Sanchez, A., and Walker, M. K. (2004). 2,3,7,8-tetrachlorodibenzo-p-dioxin reduces myocardial hypoxia and vascular endothelial growth factor expression during chick embryo development. Birth Defects Res. A Clin. Mol. Teratol. 70(2), 51-58.
6. Iyer, N. V., Kotch, L. E., Agani, F., Leung, S. W., Laughner, E., Wenger, R. H., Gassmann, M., Gearhart, J. D., Lawler, A. M., Yu, A. Y., and Semenza, G. L. (1998). Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev. 12(2), 149-162.
7. Maltepe, E., Schmidt, J. V., Baunoch, D., Bradfield, C. A., and Simon, M. C. (1997). Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT. Nature 386(6623), 403-407.
8. Roman, A. C., Carvajal-Gonzalez, J. M., Rico-Leo, E. M., and Fernandez-Salguero, P. M. (2009). Dioxin receptor deficiency impairs angiogenesis by a mechanism involving VEGF-A depletion in the endothelium and transforming growth factor-beta overexpression in the stroma. J Biol. Chem 284(37), 25135-25148.
9. Vuori, K.A.M., Soitamo, A., Vuorinen, P.J., and Nikinmaa, M. (2004) Baltic salmon (Salmo salar) yolk-sac fry mortality is associated with disturbances in the function of hypoxia-inducible transcription factor (HIF-1α) and consecutive gene expression. Aquatic Toxicology 68: 301–313
10. Maltepe, E., Achmidt, J.V., Baunoch, D, Bradfield, C.A., ad Simon, M.C. (1997) Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT. Nature 386 (6623). p.403 - 407.
11. Levy, A. P., Levy, N. S., Wegner, S., and Goldberg, M. A. (1995). Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J. Biol. Chem. 270(22), 13333-13340.
12. Compernolle, V., Brusselmans, K., Franco, D., Moorman, A., Dewerchin, M., Collen, D., and Carmeliet, P. (2003). Cardia bifida, defective heart development and abnormal neural crest migration in embryos lacking hypoxia-inducible factor-1alpha. Cardiovasc. Res. 60(3), 569-579.
13. Gassmann, M., Kvietikova, I., Rolfs, A., and Wenger, R. H. (1997). Oxygen- and dioxin-regulated gene expression in mouse hepatoma cells. Kidney Int. 51(2), 567-574.
14. Ohtake, F., Takeyama, K., Matsumoto, T., Kitagawa, H., Yamamoto, Y., Nohara, K., Tohyama, C., Krust, A., Mimura, J., Chambon, P., Yanagisawa, J., Fujii-Kuriyama, Y., and Kato, S. (2003). Modulation of oestrogen receptor signalling by association with the activated dioxin receptor. Nature 423(6939), 545-550.
15. Masabumi Shibuya (2002) Vascular Endothelial Growth Factor Receptor Family Genes: When Did the Three Genes Phylogenetically Segregate? Biol. Chem., 383: 1573 – 1579